Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 104

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 104
---
 year 2023 This was mainly due to increased demand for mouthwash and handwash in fiscal year 2024, which was a result of an increase in global awareness of personal hygiene. Moreover, the average unit price of personal care products increased by 4.5% from $13.9 in fiscal year 2023 to $14.6 in fiscal year 2024. The increase in unit selling price was mainly due to the rise in selling price of high-demanded products including mouthwash and handwash, as a result of increased purchase costs.

<div align='center'>58</div>

Sale of water filters and related products

Our sales of water filters and related products increased by $32,593 or 9.7% from $337,426 for the year ended March 31, 2023 to $370,019 for the year ended March 31, 2024. The increase in revenue from water filters and related products was driven by the increase in quantity sold, which was partially offset by a decrease in the average selling price. In fiscal year 2024, we sold 6,055 units of water filters and related products, an increase of 3,631 units or 149.8% from 2,424 units sold in fiscal year 2023. This was mainly attributable to increased demand for filter cartridges and filter shells for regular replacement in fiscal year 2024. The average unit price of water filters and related products decreased by 56.1% from $139.2 in fiscal year 2023 to $61.1 in fiscal year 2024. This decrease was mainly attributable to the lower unit selling price of filter cartridges and filter shells compared to complete sets of water filters.

Cost of revenue

Our cost of revenue mainly included cost of raw materials purchased, inbound freight cost, and packaging fee. Write-down of inventory for lower of cost or net realizable value adjustment is also charged to cost of revenue. The following table sets forth the breakdown of our cost of revenue by category for the years ended March 31, 2024 and 2023, respectively.

| Cost of revenue from                  |     | For             
 the years ended 
 March 31,       
 2024            |           |     | 2023 |           |     | Variance 
 Amount   |          |   |     | % |      |    |
|:--------------------------------------|:----|:----------------|----------:|:----|:-----|----------:|:----|: